The pain points we can help with.
Margins are complex and hard to track
You're really operating several businesses in one, and they might all have different economics.
FIM funding uncertainty and delays
Depending on where you are, FIM contracts might be going strong, or a distant hope. We'll model out those what-ifs.
Pursuing margin through mission
You're balancing shareholders and stakeholders, and funding depends on getting it right with both.
Two ways in — wherever you are right now.
Here's exactly how FinanceRX Now and FinanceRX Grow show up for a food-is-medicine social enterprise.
For a food-is-medicine social enterprise, that means:
- Books that split earned revenue from grants & contracts
- Weekly cash forecast across blended funding
- Unit economics by product line or program
- Investor- and funder-ready reporting, on time
When the calls get bigger:
- A blended-capital model that satisfies investors and funders
- Cost-per-outcome you can defend to either audience
- Scenario plans for scaling earned revenue
- A board-ready story that ties mission to margin
